An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

Nephrogenic diabetes insipidus (NDI) patients produce large amounts of dilute urine. NDI can be congenital, resulting from mutations in the type-2 vasopressin receptor (V2R), or acquired, resulting from medications such as lithium. There are no effective treatment options for NDI. Activation of PKA...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCI Insight
Main Authors: Klein, Janet D., Khanna, Ish, Pillarisetti, Ram, Hagan, Rachael A., LaRocque, Lauren M., Rodriguez, Eva L., Sands, Jeff M.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2021
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119225/
https://ncbi.nlm.nih.gov/pubmed/33724959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.146419
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker